Topoisomerase II Poisoning by ICRF-193

Journal of Biological Chemistry

Volumn 276, Issue 48, 2001, Pages 44488-44494

  Huang, Kuan Chun ^a   Gao, Hanlin ^a   Yamasaki, Edith F ^a   Grabowski, Dale R ^b   Liu, Shujun ^a   Shen, Linus L ^c   Chan, Kenneth K ^a   Ganapathi, Ram ^b   Snapka, Robert M ^a,d  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b TAUSSIG CANCER INSTITUTE   (United States)

^c ABBOTT LABORATORIES   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOASSAY; CROSSLINKING; DETERGENTS; DNA; DRUG PRODUCTS; PROTEINS;

CATALYTIC INHIBITORS;

CATALYST POISONING;

2,3 BIS(3,5 DIOXO 1 PIPERAZINYL)BUTANE; ANTINEOPLASTIC AGENT; DETERGENT; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE INHIBITOR; ISOENZYME; PHOSPHORUS 32; ENZYME INHIBITOR; PIPERAZINE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CATALYSIS; CYTOTOXICITY; DNA CLEAVAGE; DNA DAMAGE; DRUG SELECTIVITY; HUMAN; HUMAN CELL; INTOXICATION; PRIORITY JOURNAL; PROTEIN DENATURATION; CELL CULTURE; CELL NUCLEUS; DOSE RESPONSE; ENZYME SPECIFICITY; ENZYMOLOGY; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; TIME; WESTERN BLOTTING;

MINK CELL FOCUS-FORMING VIRUS;

BASE SEQUENCE; BLOTTING, WESTERN; CATALYSIS; CELL NUCLEUS; DNA TOPOISOMERASES, TYPE II; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HUMAN; MOLECULAR SEQUENCE DATA; PIPERAZINES; SUBSTRATE SPECIFICITY; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0035976924     PISSN: 00219258     EISSN: None     Source Type: Journal    
DOI: 10.1074/jbc.M104383200     Document Type: Article

References (37)

1. Creighton, A. M., Hellmann, K., and Whitecross, S. (1969) Nature 222, 384-385
2. Creighton, A. M. (1970) Prog. Antimicrob. Anticancer Chemother. 1, 167-169
3. Herman, E. H., Witiak, D. T., Hellmann, K., and Waravdekar, V. S. (1982) Adv. Pharmacol. Chemother. 19, 249-290
4. Witiak, D. T., and Wei, Y. (1990) Prog. Drug Res. 35, 249-363
5. Creighton, A. M., and Birnie, G. D. (1970) Int. J. Cancer 5, 47-54
6. Hempel, A., Camerman, N., and Camerman, A. (1982) J. Am. Chem. Soc. 104, 3453-3456
7. Tanabe, K., Ikegami, Y., Ishida, R., and Andoh, T. (1991) Cancer Res. 51, 4903-4908
8. Hasinoff, B. B., Kuschak, T. I., Yalowich, J. C., and Creighton, A. M. (1995) Biochem. Pharmacol. 50, 953-958
9. Snapka, R. M., Woo, S. H., Blokhin, A. V., and Witiak, D. T. (1996) Biochem. Pharmacol. 52, 543-549
10. Permana, P. A., Ferrer, C. A., and Snapka, R. M. (1994) Biochem. Biophys. Res. Commun. 201, 1510-1517
11. Ishida, R., Hamatake, M., Wasserman, R. A., Nitiss, J. L., Wang, J. C., and Andoh, T. (1995) Cancer Res. 55, 2299-2303
12. Liu, L. F. (1989) Annu. Rev. Biochem. 58, 351-375
13. Snapka, R. M. (1986) Mol. Cell. Biol. 6, 4221-4227
14. Sehested, M., and Jensen, P. B. (1996) Biochem. Pharmacol. 51, 879-886
15. Shin, C.-G., Strayer, J. M., Wani, M. A., and Snapka, R. M. (1990) Teratogen. Carcinogen. Mutagen. 10, 41-52
16. Snapka, R. M., and Yamasaki, E. F. (1996) in The SV40 Replicon Model for Analysis of Anticancer Drugs (Snapka, R. M., ed) pp. 65-100, Academic Press, San Diego
17. Roca, J., Ishida, R., Berger, J. M., Andoh, T., and Wang, J. C. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 1781-1785
18. Jensen, L. H., Nitiss, K. C., Rose, A., Dong, J. W., Zhou, J. F., Hu, T., Osheroff, N., Jensen, P. B., Sehested, M., and Nitiss, J. L. (2000) J. Biol. Chem. 275, 2137-2146
19. Gao, H. L., Huang, K. C., Yamasaki, E. F., Chan, K. K., Chohan, L., and Snapka, R. M. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 12168-12173
20. Herzog, C. E., Holmes, K. A., Tuschong, L. M., Ganapathi, R., and Zwelling, L. A. (1998) Cancer Res. 58, 5298-5300
21. Gao, H., Yamasaki, E. F., Chan, K. K., Shen, L. L., and Snapka, R. M. (2000) Cancer Res. 60, 5937-5940
22. Strumberg, D., Nitiss, J. L., Dong, J. W., Kohn, K. W., and Pommier, Y. (1999) J. Biol. Chem. 274, 28246-28255
23. Subramanin, D., Kraut, E., Staubus, A., Young, D. C., and Muller, M. T. (1995) Cancer Res. 55, 2097-2103
24. Snapka, R. M., Gao, H., Grabowski, D. R., Brill, D., Chan, K. K., Li, L., Li, G. C., and Ganapathi, R. (2001) Biochem. Biophys. Res. Commun. 280, 1155-1160
25. Felix, C. A., Lange, B. J., Hosler, M. R., Fertala, J., and Bjornsti, M. A. (1995) Cancer Res. 55, 4287-4292
26. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd Ed., pp. 13.78-13.104 Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
27. Tabata, M., Tabata, R., Grabowski, D. R., Bukowski, R. M., Ganapathi, M. K., and Ganapathi, R. (2001) J. Biol. Chem. 276, 8029-8036
28. Zwelling, L. A., Hinds, M., Chan, D., Mayes, J., Sie, K. L., Parker, E., Silberman, L., Radcliffe, A., Beran, M., and Blick, M. (1989) J. Biol. Chem. 264, 16411-16420
29. Sundin, O., and Varshavsky, A. (1980) Cell 21, 103-114
30. Weaver, D. T., Fields-Berry, S. C., and DePamphilis, M. L. (1985) Cell 41, 565-575
31. Snapka, R. M., Powelson, M. A., and Strayer, J. M. (1988) Mol. Cell. Biol. 8, 515-521
32. Ishida, R., Sato, M., Narita, T., Utsumi, K. R., Nishimoto, T., Morita, T., Nagata, H., and Andoh, T. (1994) J. Cell Biol. 126, 1341-1351
33. Hasinoff, B. B., Kuschak, T. I., Creighton, A. M., Fattman, C. L., Allan, W. P., Thampatty, P., and Yalowich, J. C. (1997) Biochem. Pharmacol. 53, 1843-1853
34. Mao, Y., Sun, M., Desai, S. D., and Liu, L. F. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 4046-4051
35. Mao, Y., Desai, S. D., and Liu, L. F. (2000) J. Biol. Chem. 275, 26066-26073
36. Van Hille, B., Clerc, X., Creighton, A. M., and Hill, B. T. (1999) Br. J. Cancer 81, 800-807
37. Muñoz, P., Zdzienicka, M. Z., Blanchard, J. M., and Piette, J. (1998) Mol. Cell Biol. 18, 5797-5808